Roger Brian Cole-Baker
Direktor/Vorstandsmitglied bei Lypanosys Pte Ltd.
Profil
Roger Brian Cole-Baker is currently a Director at Lypanosys Pte Ltd., a Member at the New Zealand Institute of Chartered Accountants, and a Trustee at Parnell Trust.
He was formerly a Director at Lypanosys (NZ) Ltd.
He obtained an undergraduate degree from Auckland University.
Aktive Positionen von Roger Brian Cole-Baker
Unternehmen | Position | Beginn |
---|---|---|
Lypanosys Pte Ltd.
Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Direktor/Vorstandsmitglied | 06.06.2011 |
New Zealand Institute of Chartered Accountants
New Zealand Institute of Chartered Accountants Miscellaneous Commercial ServicesCommercial Services New Zealand Institute of Chartered Accountants operates as an institute of chartered accountants. The company is headquartered in Wellington, New Zealand. | Corporate Officer/Principal | 06.06.2011 |
Parnell Trust | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Roger Brian Cole-Baker
Unternehmen | Position | Ende |
---|---|---|
Lypanosys (NZ) Ltd.
Lypanosys (NZ) Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys (NZ) Ltd. engages in the manufacture of pharmaceutical products. The company was founded on December 20, 2007 and is headquartered in Auckland, New Zealand. | Direktor/Vorstandsmitglied | - |
Ausbildung von Roger Brian Cole-Baker
Auckland University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Lypanosys (NZ) Ltd.
Lypanosys (NZ) Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys (NZ) Ltd. engages in the manufacture of pharmaceutical products. The company was founded on December 20, 2007 and is headquartered in Auckland, New Zealand. | Health Technology |
Lypanosys Pte Ltd.
Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Health Technology |
New Zealand Institute of Chartered Accountants
New Zealand Institute of Chartered Accountants Miscellaneous Commercial ServicesCommercial Services New Zealand Institute of Chartered Accountants operates as an institute of chartered accountants. The company is headquartered in Wellington, New Zealand. | Commercial Services |
Parnell Trust |